Victor Fujimoto, MD

Director of UCSF In Vitro Fertilization

Dr. Victor Fujimoto, director of the UCSF In Vitro Fertilization Program, is a specialist in reproductive endocrinology and fertility. His area of expertise includes in vitro fertilization technologies and the development of non-invasive techniques for gynecologic treatment. A former fertility patient himself, Fujimoto is aware of the emotional experience many infertile couples face. He believes women should fully understand their reproductive potential and treatment choices.

Fujimoto earned a medical degree at the University of California at San Diego. He completed a residency at the Mayo Graduate School and fellowship training at UCSF. He began a clinical practice at the University of Washington in 1993.

Clinics

Center for Reproductive Health at Mission Bay
499 Illinois St., Sixth Floor
San Francisco, CA 94158
Phone: (415) 353-7475
Fax: (415) 353-7744

Hours: Monday to Friday
8 a.m. – 4:45 p.m.
Saturday and Sunday apts. available for patients undergoing treatment

Center for Reproductive Health at Mount Zion
2356 Sutter St., Seventh Floor
San Francisco, CA 94115
Phone: (415) 353-7475
Fax: (415) 353-7744

Hours: Monday to Friday
8 a.m. – 4:45 p.m.
Saturday and Sunday apts. available for patients undergoing treatment

Conditions & Treatments

Academic Title

Professor

More about Victor Fujimoto

Additional Languages

Japanese

Education

University of California San Diego School of Medicine 1986

Residencies

Mayo Graduate School, Obstetrics and Gynecology 1990

Fellowships

UCSF Medical Center, Reproductive Endocrinology 1993

Selected Research and Publications

  1. Yamamoto A, Johnstone EB, Bloom MS, Huddleston HG, Fujimoto VY. A higher prevalence of endometriosis among Asian women does not contribute to poorer IVF outcomes. J Assist Reprod Genet. 2017 Jun; 34(6):765-774.
  2. Kim K, Bloom MS, Fujimoto VY, Browne RW. Associations between PON1 enzyme activities in human ovarian follicular fluid and serum specimens. PLoS One. 2017; 12(2):e0172193.
  3. Bloom MS, Fujimoto VY, Storm R, Zhang L, Butts CD, Sollohub D, Jansing RL. Persistent organic pollutants (POPs) in human follicular fluid and in vitro fertilization outcomes, a pilot study. Reprod Toxicol. 2017 Jan; 67:165-173.
  4. Ingle ME, Bloom MS, Parsons PJ, Steuerwald AJ, Kruger P, Fujimoto VY. Associations between IVF outcomes and essential trace elements measured in follicular fluid and urine: a pilot study. J Assist Reprod Genet. 2017 Feb; 34(2):253-261.
  5. Kim K, Bloom MS, Browne RW, Bell EM, Yucel RM, Fujimoto VY. Associations between follicular fluid high density lipoprotein particle components and embryo quality among in vitro fertilization patients. J Assist Reprod Genet. 2017 Jan; 34(1):1-10.
  6. Bloom MS, Mok-Lin E, Fujimoto VY. Bisphenol A and ovarian steroidogenesis. Fertil Steril. 2016 09 15; 106(4):857-63.
  7. Quinn M, Fujimoto V. Racial and ethnic disparities in assisted reproductive technology access and outcomes. Fertil Steril. 2016 05; 105(5):1119-1123.
  8. Kim K, Bloom MS, Fujimoto VY, Bell EM, Yucel RM, Browne RW. Variability in follicular fluid high density lipoprotein particle components measured in ipsilateral follicles. J Assist Reprod Genet. 2016 Mar; 33(3):423-430.
  9. Butts CD, Bloom MS, Frye CA, Walf AA, Parsons PJ, Steuerwald AJ, Ilonze C, Fujimoto VY. Urine cortisol concentration as a biomarker of stress is unrelated to IVF outcomes in women and men. J Assist Reprod Genet. 2014 Dec; 31(12):1647-53.
  10. Kim K, Bloom MS, Kruger PC, Parsons PJ, Arnason JG, Byun Y, Goins S, Fujimoto VY. Toxic metals in seminal plasma and in vitro fertilization (IVF) outcomes. Environ Res. 2014 Aug; 133:334-7.
  11. Kim K, Bloom MS, Fujimoto VY, Browne RW. Number of specimens required to estimate average follicular fluid high-density lipoprotein particle components in women undergoing in vitro fertilization. Fertil Steril. 2014 Jun; 101(6):e44.
  12. Lathi RB, Liebert CA, Brookfield KF, Taylor JA, vom Saal FS, Fujimoto VY, Baker VL. Conjugated bisphenol A in maternal serum in relation to miscarriage risk. Fertil Steril. 2014 Jul; 102(1):123-8.
  13. Bloom MS, Kim K, Fujimoto VY, Browne RW. Variability in the components of high-density lipoprotein particles measured in human ovarian follicular fluid: a cross-sectional analysis. Fertil Steril. 2014 May; 101(5):1431-40.
  14. Gerona RR, Woodruff TJ, Dickenson CA, Pan J, Schwartz JM, Sen S, Friesen MW, Fujimoto VY, Hunt PA. Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population. Environ Sci Technol. 2013; 47(21):12477-85.
  15. Spitzer T, Fujimoto VY. Ethnic differences in assisted reproductive technologies outcomes. Semin Reprod Med. 2013 Sep; 31(5):360-4.
  16. Buck Louis GM, Peterson CM, Chen Z, Croughan M, Sundaram R, Stanford J, Varner MW, Kennedy A, Giudice L, Fujimoto VY, Sun L, Wang L, Guo Y, Kannan K. Bisphenol A and phthalates and endometriosis: the Endometriosis: Natural History, Diagnosis and Outcomes Study. Fertil Steril. 2013 Jul; 100(1):162-9.e1-2.
  17. Kim D, Bloom MS, Parsons PJ, Fitzgerald EF, Bell EM, Steuerwald AJ, Fujimoto VY. A pilot study of seafood consumption and exposure to mercury, lead, cadmium and arsenic among infertile couples undergoing in vitro fertilization (IVF). Environ Toxicol Pharmacol. 2013 Jul; 36(1):30-4.
  18. Peterson CM, Johnstone EB, Hammoud AO, Stanford JB, Varner MW, Kennedy A, Chen Z, Sun L, Fujimoto VY, Hediger ML, Buck Louis GM. Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study. Am J Obstet Gynecol. 2013 Jun; 208(6):451.e1-11.
  19. Bloom MS, Kim K, Kruger PC, Parsons PJ, Arnason JG, Steuerwald AJ, Fujimoto VY. Associations between toxic metals in follicular fluid and in vitro fertilization (IVF) outcomes. J Assist Reprod Genet. 2012 Dec; 29(12):1369-79.
  20. Louis GM, Peterson CM, Chen Z, Hediger ML, Croughan MS, Sundaram R, Stanford JB, Fujimoto VY, Varner MW, Giudice LC, Kennedy A, Sun L, Wu Q, Kannan K. Perfluorochemicals and endometriosis: the ENDO study. Epidemiology. 2012 Nov; 23(6):799-805.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.